| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999771 | Urologic Oncology: Seminars and Original Investigations | 2015 | 4 Pages |
Abstract
BCG-refractory and BCG-relapsing categories differentiate BCG-failed patients into high-and lower-risk prognostic groups that may be useful in guiding treatment strategies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Harry W. M.D., Tanya N. B.S., M.P.H, Guido M.D.,